Proreo Pharma Innovation AG
http://www.proreopharma.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Proreo Pharma Innovation AG
AmpliPhi swallows SPS to expand bacteriophage breadth
Two companies specialising in bacteriophage technologies are to join forces as AmpliPhi, which has operations in the UK and US, prepares to acquire Sydney, Australia-based Special Phage Services (SPS). The all-share transaction will create "the world's leading anti-infective company focused on bacteriophage-based therapies", they claim.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
-
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice